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Abstract
 .We have shown that fusion of small unilamellar vesicles SUV with outer mitochondrial membranes occurs at
w xphysiological pH Cortese et al., 1991, J. Cell Biol., Vol. 113, 1331–1340 . The proteins driving this process could be
involved in mitochondrial membrane fusion, which is presently poorly understood. In this study, we release from rat liver
 .mitochondria a soluble protein fraction SF that increases fusion at neutral pH measured by membrane fusion assays
 .MFAs . Since this fusogenic activity was specifically enhanced by GTP, we separate SF by GTP affinity chromatography
.  . .  .into: i a flow-through subfraction G1 containing numerous proteins with low GTP affinity; and ii a subfraction G2
which may contain GTP-binding proteins. A novel array of MFAs is developed to study the fusogenic properties of these
 .fractions, measuring the merging of membranes membrane-mixing or the mixing of intravesicular aqueous contents
 . . .content-mixing . The MFAs use: a SUVrlarge unilamellar vesicles, lacking mitochondrial membranes; b
.SUVrmitochondria, reconstituting membrane–mitochondrial interactions; and c mitochondriarmitochondria, mimicking
.mitochondrial fusion. The results indicate that: i G1 contains GTP-independent, in vitro fusogenic proteins that are not
.sufficient to induce mitochondrial fusion; and ii G2 contains GTP-dependent proteins that stimulate mitochondrial fusion at
X X  .  .Abbreviations: BCECF, fluorescent form of BCECF-AM; BCECF-AM,2 ,7 -bis- 2-carboxyethyl -5- and 6 -carboxyfluorescein; CM,
content-mixing; CME, fluorescent form of CMEDA; CMEDA, 5-chloromethyleosin diacetate; FITC-BSA, fluorescein-5-isothiocyanate-
labeled bovine serum albumin; G1, subfraction from SF pool obtained as a flow-through in GTP agarose chromatography; G2, subfraction
from SF pool retained in GTP agarose chromatography; H medium, 300 mOsm solution composed of 220 mM mannitol, 70 mM300
 .  .  .sucrose, 2 mM Hepes pH 7.4 and 0.05% fatty acid-free bovine serum albumin BSA ; LUV, large unilamellar vesicles; MFA s ,
 .membrane fusion assay s ; Mitochondriarmitochondria MFA, MFA that detects fusion between mitochondrial populations; MM,
membrane-mixing; OMM, outer mitochondrial membrane; R , octadecylrhodamine; RCR, respiratory control ratio, defined as the ratio18
 . between oxygen consumption of mitochondria in respiratory state 3 in the presence of substrate and ADP and respiratory state 4 in the
.presence of substrate alone ; RET, resonance energy transfer; RSQ, relief of self-quenching; SUV, small unilamellar vesicles; SF, soluble
protein fraction derived from OMM; SUVrLUV MFA, MFA that detects fusion between SUV and LUV; SUVrmitochondria MFA,
MFA that detects fusion between SUV and mitochondria
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neutral pH. The MFAs described here could be used to monitor the isolation of active proteins from these subfractions and
to define the mechanism of intermitochondrial membrane fusion. q 1998 Elsevier Science B.V. All rights reserved.
Keywords: Guanine nucleotide; Liposome; Liver mitochondrion; Resonance energy transfer; Mitochondrial fusion; Fluorescence
1. Introduction
Mitochondria exhibit elongated or spherical shapes
in many cell types, thus its name from the Greek
w xmitos: ‘thread’ and kondria: ‘bead’ 1 . From early
microscopic observations of mitochondrial morphol-
w x w xogy 2 and motility 3,4 , to modern studies using
w xvideo-enhanced and fluorescence microscopy 5–7 ,
we have come to envision mitochondria as a cellular
structure with the ability to fuse and fragment. Mito-
w xchondrial fusion occurs during cell development 8,9
and in several disease states that produce liver
w xmegamitochondria 10 . It has also been postulated to
explain fast redistribution of mitochondrial DNA in
w xHeLa cells 11 , DNA exchange between organelle
w xcompartments 12,13 and mitochondrial genetic mix-
ing induced by plasmids found in plasmodium strains
w x14,15 . The formation of a single yeast mitochon-
w xdrion 16,17 might be also a result of protein-media-
ted membrane fusion and yeast proteins relevant to
mitochondrial morphology changes have been de-
w xtected by mutant analysis 18,19 . In spite of all these
observations and of many others with biological sys-
tems where mitochondrial fusion has been detected or
w xpostulated 20–23 , mitochondrial fusion is generally
viewed as a spontaneous, unregulated process.
Although progress is being made in understanding
the relationship between mitochondrial inheritance
w xand mitochondrial fusion in yeast 18,19,24 , it is
lacking in mammalian cells, where different sig-
nalling pathways may be acting to regulate the pro-
cess. It is also unclear how mitochondrial fusion
helps to maintain the structure of mitochondria
through cycles of cell division, or increases the redis-
tribution of soluble ions, genetic material and mem-
w xbrane potentials 25,26 between mitochondria sub-
jected to different microenvironments. Disruption of
this dynamic mitochondrial system, sometimes known
w xas ‘reticulum mitochondriale’ 27 , are apparent as
alterations of morphology, collectively named mito-
w xchondrial pleomorphism 10 . Uncovering the under-
lying biochemical mechanism for mammalian mito-
chondrial fusion can thus bring a variety of physio-
logical and pathological conditions to a new under-
standing and possibly to genetic manipulation. In this
report, we have undertaken the first steps towards
identifying the proteins responsible for rat liver mito-
chondrial fusion.
During the development of a liposome-mediated,
low pH-based method to deliver high molecular
weight fluorescence probes into the intermembrane
w xspace of intact mitochondria 28–30 , we detected a
component of membrane fusion at neutral pH that
could be mediated by outer mitochondrial membrane
 .  .OMM proteins. The membrane fusion assay MFA
w xused 28–30 was limited to measuring membrane-
 .and content-mixing MM and CM, respectively be-
 .tween small unilamellar vesicles SUV and mito-
chondria, which may only partially represent the
molecular events occurring during intermitochondrial
fusion. Thus, it was necessary to develop additional
MFAs to test all aspects of the process of mitochon-
drial fusion. This paper presents such an array of
mitochondrial MFAs. We developed a simple, mito-
chondria-free MFA measuring membrane fusion be-
 .tween SUV and large unilamellar vesicles LUV and
a MFA resembling the fusion between mitochondria,
where MM between outer membranes or CM be-
tween mitochondrial matrices can be monitored con-
tinuously. Using these MFAs, we now show that a
solubilized OMM protein fraction named SF stimu-
 .lated membrane fusion i.e., is fusogenic and that
GTP enhances the effect. Soluble subfractions de-
rived SF through GTP affinity chromatography have
a differential behavior under these MFAs: the sub-
fraction that does not bind to GTP affinity columns
contains proteins that enhance intermitochondrial
binding and the protein pool retained by the GTP-bi-
nding column contains proteins that stimulate GTP-
dependent mitochondrial fusion.
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2. Materials and methods
2.1. Materials
 .Fatty acid-free bovine serum albumin BSA ,
X  .EDTA, GDP, guanosine-5 -O- 2-thiodiphosphate
 . X  .GDPb S , GTP, guanosine-5 -O- 3-thiotriphosphate
 .  .GTPg S , D-mannitol, sodium dodecyl sulfate SDS ,
succinate, sucrose and Triton X-100 were purchased
 .from Sigma Chemical St. Louis, MO . Asolectin
was purchased from Associated Concentrates
 .Woodside, L.I., NY , digitonin from Calbiochem
 .La Jolla, CA and Hepes was obtained from
Boehringer Mannheim Biochemicals Indianapolis,
.IN . All other chemicals were of the highest purity
available commercially. Sephadex G-25 and G-200
 .were obtained from Pharmacia Uppsala, Sweden ,
GTP-ActiGel-ALD was from Sterogene Biosepara-
 .tions Arcadia, CA and Centriprep-10 concentrators
 . 10 kD-molecular weight cutoff from Amicon Be-
.verly, CA . BCECF-AM, CMEDA, F , F and R16 18 18
 .chloride salt were purchased from Molecular Probes
 .Eugene, OR . FITC-BSA was prepared as described
w x 28,31 , or purchased commercially Molecular
.Probes .
2.2. Mitochondria-deri˝ed preparations
Liver mitochondria were isolated from male
w xSprague–Dawley rats 28,32 and then resuspended
in isosmotic H medium. Respiratory control ratios300
 .RCR were used as an index of mitochondrial intact-
ness, measured polarographically with a Clark oxy-
w xgen electrode according to Cortese et al. 28,33 .
RCR values for our preparations succinaterADP
w x.system; 28 were in the range 5.0–8.0, indicative of
highly purified mitochondria.
Our goal of identifying mitochondrial proteins in-
volved in mitochondrial fusion cannot be easily ac-
complished by direct extraction from intact mito-
chondria. We have been able to use high ionic
strengthrdigitonin to perturbate extrinsic protein–
membrane interactions, releasing a soluble fraction
that may contain OMM-derived fusogenic proteins.
Isolated rat liver mitochondria obtained from eight
 .rats 5 mgrml were kept on ice for 15 min in an
incubation buffer containing 75 mM KCl, 110 mM
 .mannitol, 35 mM sucrose and 2 mM Hepes pH 7.4 .
Digitonin was then added at a concentration below
that needed to induce release of intermembrane space
enzyme markers 1 mg digitoninr100 mg mitochon-
w x.  .dria; 32 . The sample was diluted 1:15 and spun
 .for 15 min at 9770=g 48C , the supernatant was
collected and the wash step repeated. Pooled super-
 .natants were then diluted 1:4 and centrifuged for 1
 .h at 104,000=g 48C , to remove any membrane
 .fragments. The resulting soluble fraction SF was
concentrated to 2–4 mgrml using a Centriprep-10
concentrator and loaded into a GTP-agarose column
 .GTP-ActiGel-ALD . A protein mixture that does not
bind GTP-agarose was eluted first at a 1 mlrmin-flow
rate with a buffer containing 10% glycerol, 0.1 mM
 .EDTA, 0.15 mM MnCl and 10 mM Hepes pH 7.4 .2
This first protein subfraction was named G1. Proteins
bound to GTP-agarose at low ionic strength were
eluted with a high ionic strength buffer containing
10% glycerol, 0.1 mM EDTA, 0.5 M KCl and 10
 .mM Hepes pH 7.4 . This second protein subfraction
was named G2. These protein subfractions were con-
centrated to 2–4 mgrml and kept on ice for use in
experiments within 4 h. The conditions described
w xabove were based on Colombo et al. 34 , modified to
optimize separation at low protein concentration. The
same elution pattern and sample composition were
obtained if 1–5 mM GTP was used as eluant, but we
eliminated GTP additions from our preparations, thus
recovering G2 proteins in the GTP-unbound form.
w xProtein composition was assessed by SDS-PAGE 35
and protein concentrations were measured using the
w xMicroBCA protein assay 36 . Contamination of
OMM-derived fractions with mitochondrial phospho-
w xlipase A 37 could affect the results from MFAs.
Within the sensitivity of the pH-based activity assay
w x38,39 , we could not detect any phospholipase activ-
ity in SF or SF-derived fractions and a low level of
activity 0.20"0.05 Urmg mitochondrial protein
2q .with 5 mM Ca at 378C was detected for mitochon-
dria.
2.3. Fluorescence measurements
The intensity of fluorescence emission was moni-
tored digitally using a Perkin-Elmer fluorescence
spectrophotometer model 650-40 Perkin-Elmer, Nor-
.walk, CT in the ratio mode at 158C. The excitation
wavelength was 490 nm for fluorescein-linked dyes
  .5- N-hexadecanoyl aminofluorescein or F , N-oc-16
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  ..tadecyl-N- 5- fluoresceinyl thiourea or F and18
. FITC-BSA , 500 nm for BCECF fluorescent form of
X X  .  .2 ,7 -bis- 2-carboxyethyl -5- and 6 -carboxyfluo-
.rescein; BCECF-AM , 560 nm for octadecylrho-
 . damine R and 525 nm for CME fluorescent form18
.of 5-chloromethyleosin diacetate; CMEDA ; using
slit widths of 5 nm. When mitochondria were used in
our membrane fusion assays, excitation of fluores-
cein-linked dyes and BCECF was moved down to
468 nm, thus minimizing errors introduced by light
w xscattering of mitochondria 28 . The intensity of fluo-
rescein emissions from fluorescein-linked dyes 520
.  .  . nm , BCECF 525 nm , R 590 nm and CME 56518
.nm , were all collected using slit widths of 10 nm.
Quinine sulfate in 0.1 M H SO was used to monitor2 4
changes on the efficiency of fluorescence intensity,
before and after each experiment. Controls for turbid-
ity were included when appropriate and inner filter
effect corrections were those of Geren and Millet
w x40 .
( )2.4. Membrane fusion assays MFAs
( )2.4.1. Assays using relief of self-quenching RSQ
w xWe 28 have developed MFAs that measure the
 w x.merging of membrane bilayers MM; 41–43 and
 w x.the mixing of intravesicular contents CM; 44,45
during membrane fusion. The assays are based on the
increase of apparent fluorescence that fluorophores
exhibit when they are significantly diluted from a
concentrated compartment i.e., the phenomenon
.known as relief of self-quenching or RSQ .
Asolectin SUV labeled with R or encapsulating18
FITC-BSA were prepared as previously described,
including gel filtration chromatography to eliminate
fluorescence contributions from non-encapsulated
w xmaterial 28 . In our hands, asolectin SUV fuse read-
wily with mitochondrial membranes at pHs6.5 28–
x30,46 and provide an economical means to substitute
for synthetic phospholipids, when a large number of
assays have to be carried out. SUVs prepared from
synthetic lipids molar ratio 4:1 of dioleoyl-phos-
.phatidylcholine:dioleoyl-phosphatidylethanolamine
were also used in parallel assays, giving similar
 .dequenching profiles not shown . RSQ-based CM-
or MM-SUVrmitochondria MFAs were carried out
with SUV labeled with self-quenching concentrations
 .of membrane-incorporated R 70 mM; MM or18
 .soluble FITC-BSA 25 mgrml; CM , mixed with
unlabeled mitochondria 4.5 mg phospholipidr100
.mg mitochondria . Lipid concentration was estimated
w xby inorganic phosphate analysis 47 . Mitochondrial
concentration was kept below 0.5 mgrml, to avoid
light scattering artifacts and H medium without300
BSA was used for all dilutions. These MFAs were
carried out at 158C, a condition that keeps mitochon-
w xdria intact for f1 h 28 .
We monitored the effects of RSQ through continu-
ous or periodic measurements of fluorescence; pro-
teins and effectors were added at appropriate times as
described. These conditions maintain pHs7.4 dur-
ing 1 h-incubations; pH was slowly lowered to trig-
ger fusion, using calibrated amounts of 0.1 M Hepes
 .buffer pH 5.0 . The first recorded point is taken as
 .time zero fluorescence F and fluorescence at infi-0
 .nite dilution F estimated by serial dilution with‘
0.1% Triton X-100. Normalized RSQ fluorescence,
w x w xi.e., FyF r F yF , a value independent of0 ‘ 0
probe concentration, is used for interexperimental
comparison. This is analogous to show results as a
percentage of maximal attainable fusion. Results of
all MFAs shown here are the average of at least three
measurements and they represent the trend from three
different mitochondrial preparations.
We also developed a MFA where SUV fuse with
 .large unilamellar vesicles LUV . LUV were pre-
pared by repeated extrusion through polycarbonate
w xfilters 48 of a suspension containing 0.8 mg asolectin
phospholipid per ml of H medium without BSA.300
SUV labeled with self-quenching concentrations of
 . R MM-SUVrLUV MFA or FITC-BSA CM-18
.SUVrLUV MFA were prepared as described above.
In the assay cuvette, a 30:1 ratio of mg LUV phos-
pholipid:mg SUV phospholipid was kept. The assay
was carried out at 158C, with a LUV concentration of
1.2 mgrml and normalized RSQ fluorescence calcu-
lated as described above, including serial dilutions in
0.1% Triton X-100 to determine the fluorescence at
 .infinite dilution F . Medium pH was decreased with‘
buffer as described above.
To carry out a MM-mitochondriarmitochondria
 .MFA, mitochondria 0.25 mgrml was labeled with
 . R 240 mM for 15 min on ice H medium18 300
. without BSA , extensively washed 800,000-fold ef-
. w xfective dilution to remove soluble R 28 and18
exposed to unlabeled mitochondria 12 mgrml of
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R -labeled mitochondria plus 120 mgrml unlabeled18
.mitochondria . RSQ from R was measured as de-18
scribed above. The R -labeled mitochondria pre-18
w xserved 80–95% of their RCR 28 . Also, since using
0.5 mgrml BSA did not affect RSQ values measured
 .by this MFA not shown , unspecific protein-media-
ted lipid transfer such as that carried out by BSA is
not likely to explain our results. Residual digitonin
from the extraction protocol does not affect the RSQ
MM-mitochondriarmitochondria MFA. Adding digi-
tonin at concentrations that are 20-fold higher than
those calculated for the cuvette assay i.e., 0.01
.mgrml had no effect on RSQ from mitochondrial
controls, or from samples with the addition of SF, G1
 .or G2 subfractions 250 mgrml; not shown .
( )2.4.2. Assay using resonance energy transfer RET
A CM-mitochondriarmitochondria MFA was de-
veloped using RET between matrix-entrapped fluo-
rescence probes. BCECF was used as a RET donor
w x w x49–51 and CME as a RET acceptor 30,52,53 .
Mitochondria 25 mgrml in H medium without300
.  .BSA were labeled with BCECF-AM 52 mM or
 .with CMEDA 60 mM for 45 min at 158C. BCECF
remains entrapped into the mitochondrial matrix after
w xthis incubation 50 . A further incubation for 45 min
at 158C with media containing respiratory substrate
H medium with 1.5 mM K PO , 2.5 mM Na-300 2 4
.succinate, 1.5 mM MgCl and 0.5 mM Na –EDTA ,2 2
was necessary to obtain covalent linkage of CME to
matrix proteins, thus entrapping the probe into mito-
chondria. The two probes used were retained into the
mitochondrial matrix, even after extensive washes
 .800,000-fold final dilution after serial dilutions .
RCR of CMEDA- and BCECF-AM-treated samples
was 75–90% of values for untreated mitochondria.
The assay proceeds by monitoring BCECF emission
 w x.donor quenching method; 30 . Controls using donor
 .  .D - or acceptor A -labeled mitochondria exposed to
unlabeled mitochondria are also included. An assay
using BCECF-labeled plus unlabeled mitochondria
 .gave the unquenched donor intensity F , whichD
was compared with a parallel assay run using CME-
 .labeled 0.1 mgrml and BCECF-labeled mitochon-
 .dria 0.4 mgrml to obtain the quenched donor inten-
 .  .sity F . RET efficiency E was calculated asDA RET
w  .xE s 1y F rF . The maximum attainableRET D DA
 .RET taken as 100%; RET was estimated usingmax
hypotonically-lysed mixtures of mitochondria previ-
ously labeled with CME and BCECF. Based on the
above definition, the RET-based percentage of con-
w xtent-mixing was estimated as: 100) E rRET .RET max
A calibration curve was constructed using mixtures
of mitochondria labeled with BCECF-AM and
CMEDA, lysed to bring both probes into contact. To
carry out this ‘mock’ fusion assay, both probes were
entrapped into the mitochondrial matrix as described
above. Subsequently, mitochondria were hypotoni-
 .cally lysed 1:10 dilution with distilled water , pel-
leted and resuspended in H medium without BSA300
and the supernatant concentrated to obtain a 0.1
mgrml protein solution. The estimated BCECF-
CME’s spectral overlap J was 72% of the value
found for the fluorescein–rhodamine RET couple
w x30 . As only E has to be measured to estimateRET
intermitochondrial content-mixing, we have not char-
acterized this RET couple to the point of obtaining
w xstatistically-ranged interprobe distances 30 .
For the RET-based MM-mitochondriarmito-
chondria assay used in Fig. 3, two samples of mito-
chondria suspended at 0.5 mgrml in H medium300
without BSA were labeled with either R s50 mM18
or F s35 mM for 15 min on ice. A ‘mock’ fusion16
calibration curve was constructed using mitochondria
labeled with mixtures of R and F , showing that18 16
changes in RET are linear for the full 0–100% range
 .of calculated MM percentage not shown . Differ-
ences of more than 3% RET between samples can be
detected with this assay.
3. Results
 .Membrane fusion assays MFAs that measure
membrane- and content-mixing between SUV and
mitochondria, based on exposing isolated rat liver
mitochondria to SUV loaded with fluorescence probes
for 1 h at pH 7.4 and then decreasing the pH to 6.5 to
prompt probe delivery, were characterized by a large
 .increase in RSQ Fig. 1 . Mitochondria were not
structurally or functionally damaged by this proce-
w xdure 28 . These fluorescence MFAs revealed that a
component of fusion was always present at neutral
 w x.pH Fig. 3 of 28 , suggesting that proteins present in
the OMM could be responsible. We thus decided to
separate from the OMM protein fractions capable of
enhancing this effect. Experimentation led to a solu-
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 .Fig. 1. A mitochondrial membrane fusion assay MFA shows
nucleotide-dependent effects of an outer membrane-derived, solu-
 .ble protein fraction SF . The RSQ-based M M -
SUVrmitochondria MFA was carried out. Mitochondria were
 .incubated in H medium without BSA 0.2 mgrml; 158C ,300
 .  .followed by the addition time equal to zero of: a R -labeled18
 .SUV mitochondrial control; ‘ , R -labeled SUV plus SF18
 .  .  .fraction 250 mgrml; B and b Same MFA as in a , with
 .addition of R -labeled SUV mitochondrial control; ‘ , R -18 18
 .labeled SUV plus 0.5 mM GTP v , R -labeled SUV plus 0.518
 .  .mM ATP B and R -labeled SUV plus SF 250 mgrml and18
 .GTP 200 mM; I . After a 60 min-incubation at pH 7.4, pH was
 .lowered to 6.5 by addition 5% vrv of 1 M Hepes pH 5.0 and
measurements taken every 15 s.
 .ble fraction named SF see Section 2 which in-
creased the neutral pH component of membrane fu-
sion RSQ-based MM-SUVrmitochondria MFA; Fig.
.1a . The low pH-induced fusion was not affected,
suggesting that only the efficiency of fusion at neu-
tral pH was altered, not the maximal attainable fu-
sion. Membrane fusion at neutral pH appears to be
 .specifically modified by nucleotides Fig. 1b . Addi-
tion of ATP did not modify substantially the fusion
profile, while addition of GTP increased the neutral
pH component. Joint addition of SF and GTP in-
creased membrane fusion at neutral pH to near the
maximum measurable on this MFA.
 .Using a mitochondria-free MFA SUVrLUV , we
showed that the GTP dependence of the effect of SF
on mitochondrial membrane fusion requires the pres-
ence of intact mitochondria. Addition of SF to the
SUVrLUV MFA increased fusion at neutral pH Fig.
.2 however, addition of 1 mM GTP did not further
increase fusion at neutral pH. Content-mixing changes
parallel membrane-mixing changes detected by this
 .assay not shown . The limited increase of mem-
brane-mixing by the addition of SF at neutral pH
suggests that proteins present in SF could cause
vesicle membrane fusion even at neutral pH and in
the absence of mitochondrial membrane proteins.
A further test for the effects of the SF protein pool
 .was carried out Fig. 3 , using a resonance energy
 .transfer RET assay that is exceedingly sensitive to
any amount of intermembrane lipid-mixing, whether
caused by fusion or intimate membrane contact. The
Fig. 2. Effect of SF and GTP on a mitochondria-free MFA. The
RSQ-based, MM-SUVrLUV MFA described was used. LUV
were incubated in H medium without BSA, followed by the300
 .  .  .addition at time equal to zero of: a R -labeled SUV —‘ ; b18
 .  .  .  .Same as in a , plus 1 mM GTP —I ; c Same as in a , plus
 .  .  .600 mgrml SF —v ; and d Same as in c , plus 1 mM GTP
 .
–––B .
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 .Fig. 3. The effect of SF on a resonance energy transfer RET -
based intermitochondrial MM-MFA. RET between mitochondrial
 .populations 0.5 mgrml in H medium without BSA labeled300
 .with R and F was measured as described for: a untreated18 16
 .  .mitochondria ‘ ; b mitochondria after the addition of the SF
 .  .fraction 250 mgrml; B ; and c mitochondria washed three
 .times with 145 mM KCl, 2 mM Hepes pH 7.4 I . Percentage
of membrane-mixing was calculated by comparison with a cali-
bration assay.
RET-based MM-mitochondriarmitochondria MFA
 .detects RET change over time Fig. 3 , as the probes
slowly equilibrate between mitochondrial mem-
branes. Also, as occurred with the MM-
SUVrmitochondria and MM-SUVrLUV MFAs, ad-
dition of SF caused an increase in the rate of MM
over a 1 h-incubation period at neutral pH. When
mitochondria were pretreated by washing at high,
physiological ionic strength 125 mM KCl, 2 mM
.Hepes pH 7.4 , there was very little time-dependent
change in RET. This treatment also decreased mem-
brane fusion between SUV and mitochondria not
.shown . We used physiological ionic strength washes
to substitute the digitoninrionic strength treatment,
since detergents perturbate this MFA. Physiological
ionic strength removes most of the components of the
 .SF pool not shown . High ionic washes did not
affect mitochondrial function; RCR from washed,
labeled mitochondria were 85–95% of control, intact
mitochondria. Although not conclusively proving
mitochondrial fusion, our results strongly suggest that
proteins contained in SF can enhance intermitochon-
 .drial binding see Section 4 .
The GTP-dependent effect of SF on fusion be-
 .tween SUV and mitochondria or LUV indicates that
this fraction may contain soluble GTP-sensitive pro-
teins or subunits from transmembrane proteins in-
volved in mitochondrial fusion. Thus, we separated
the proteins contained in the SF protein pool using
GTP-affinity chromatography. Two distinct protein
 .fractions were obtained Fig. 4a : the flow-through
 .protein pool G1 contains most of the proteins pre-
sent in SF and the protein pool retained in the column
Fig. 4. Separation of the SF protein pool into fractions with
 .differential fusogenic proteins. a Coomasie Blue protein stain-
 .ing of a 12.5% SDS-acrylamide gel. Molecular weights in kDa
are shown in the left. SF, soluble protein pool derived from
 .mitochondria; G1 and G2, fractions eluted from GTP-agarose. b
MM-SUVrmitochondria MFA used in Fig. 1, with the addition
 .  .of G1 I and G2 v in the amounts indicated in the x-axis.
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 .G2 has only a few distinctive bands. Both subfrac-
tions were tested using the MM-SUVrmitochondria
 .MFA and the resulting titrations Fig. 4b show a
differential behavior. G1 exhibits a linear, concentra-
tion-dependent effect on membrane-mixing, as ex-
pected from a non-specific fusogenic fraction that
facilitates intermembrane contact between SUV and
mitochondria. Within the same range of protein addi-
tions, the G2 subfraction leads to a saturation behav-
ior and a plateau was reached with the addition of
only 50 mg of G2 per cuvette assay.
We conducted several additional tests with the G1
 .and G2 subfractions Fig. 5 . Addition of G1 in-
creases MM and CM in both the SUVrLUV and
 .SUVrmitochondria MFAs cf. Fig. 4b . This again
suggests that this subfraction contains fusogenic pro-
teins. Addition of G2 affected the SUVrLUV MFA
to a lesser extent than G1. G2 increased MM in the
SUVrmitochondria MFA, but did not affect the CM-
SUVrmitochondria MFA. This indicates that G2 is
inducing intermembrane contacts between SUV and
 .Fig. 5. Membrane fusion assays MFAs show differential fuso-
genic properties of OMM-derived protein fractions. The MFAs
 .using relief of self-quenching RSQ of SUV labeled with an
excess of soluble, fluorescent probes MM with R and CM18
.  .with FITC-BSA described in Section 2 were carried out: i with
mitochondria-free preparations CM-SUVrLUV and MM-
.  .SUVrLUV ; and ii with mixed vesicle–mitochondrial prepara-
 .tions CM-SUVrmitochondria and MM-SUVrmitochondria .
 .The assays were carried out at pH 7.4 without additions None ,
 .  .  .or the samples were treated with: a G1 250 mgrml ; b same
 .  .  .  .as in a , plus GTP 200 mM; G1qGTP ; c G2 250 mgrml ;
 .  .  .  .d G2 same as in c , plus GTP 200 mM; G2qGTP ; e SF
 .  .  .  .500 mgrml ; f SF as in e , plus GTP 200 mM; SFqGTP .
Bar lines are indicated in the right.
Fig. 6. Fluorescence probes that produce relief of self-quenching
compatible with a MM-mitochondriarmitochondria MFA. The
RSQ-based MM-mitochondriarmitochondria MFA described was
 .carried out using R s500 mM v , F s500 mM18 18
 .  .
–––I , or F s500 mM –P–’ to label mitochondria. The16
 .MFA was started by the addition time equal to zero of labeled
mitochondria to a 10-fold greater excess of unlabeled mitochon-
 .dria 0.5 mgrml final concentration . Before the MFA was
carried out, mitochondria were washed twice with 145 mM KCl,
2 mM Hepes pH 7.4. After a 1 h-incubation at pH 7.4, the pH
was lowered to 6.5 as described in Fig. 1.
mitochondria rather than fusion. GTP addition did not
modify G2’s effect on the CM- and MM-SUVrLUV
MFA, suggesting that other OMM proteins are neces-
sary for GTP-dependent effects. Addition of SF in-
creased MM and CM in the SUVrmitochondria MFA
 .  .cf. Fig. 1a , but further addition of GTP 0.5 mM
 .only affected MM in this assay cf. Fig. 1b . SF had
less effect on these MFAs than G1 or G2, suggesting
interactions between G1 and G2 proteins. Since both
SF and G2 show GTP-dependent effects in MFAs,
while G1 effects are GTP-insensitive, G2 might con-
tain the protein or proteins that specifically partici-
pate in GTP-dependent events of membrane fusion.
A RSQ-based MFA was developed to assay inter-
mitochondrial membrane-mixing. Although we have
used R in another RSQ-based MM-MFA involving18
w xSUV 28 , we validated here its use for mitochondrial
 .membranes Fig. 6 . Use of fluorescein-linked probes
at self-quenching concentrations was not optimal, as
F and F showed large RSQ increases at neutral16 18
pH. This suggests collisional migration of F and F16 18
between labeled and unlabeled membranes, which
will give a false positive in a RSQ MFA. The effect
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appears at the high concentrations of these probes
used in this RSQ MFA, but was not apparent at the
concentrations used in the MM-MFA shown in Fig.
3. Fluorescein-linked probes are also pH-sensitive
w x28,29,49,51 and lowering pH to prompt membrane
fusion decreases their fluorescence, obscuring any
 .signal from low pH-induced RSQ Fig. 6 . Fluores-
cence from R is not pH-sensitive, showing a low18
RSQ signal at neutral pH and a small increase when
pH was lowered, as expected from a dye that does
not migrate between mitochondrial membranes
through collisional events. R has a net positive18
charge and it may bind very strongly to the nega-
tively charged mitochondrial membrane, while the
negatively charged F and F would be easily re-16 18
moved from these membranes. Thus, R seems the18
appropriate choice for our RSQ MM-MFA involving
mitochondrial membranes. Phospholipid-linked
probes could not be efficiently incorporated into
mitochondrial membranes without detergents or sol-
 .vents that perturb mitochondrial function not shown .
We used the RSQ MM-mitochondriarmito-
chondria MFA to determine the effect of G1 and G2
 .on intermitochondrial MM Fig. 7a . Addition of G1
increased MM substantially, but the increase was
GTP insensitive. G2 did increase MM, as with the
MM-SUVrmitochondria MFA. Membrane-mixing
increased further when GTP was added after a 1
h-incubation at neutral pH. We also tested the speci-
ficity of the guanosine nucleotide binding with the
 .MM-mitochondriarmitochondria MFA Fig. 7b .
GTP stimulated MM on controls and G-2 treated
samples and GTPg S only affected this MFA when
added together with G2. GDP and GDPb S lacked
 .significant effect on MM see Section 4 . Thus, in
this mitochondrial MFA G2 showed its distinctive
GTP-mediated MM increase, indicating that some
component of G2 acts stimulating GTP-dependent
mitochondrial membrane interactions. However, an
additional CM-mitochondriarmitochondria MFA was
necessary, to clarify if G1 and G2-dependent effects
lead to mitochondrial fusion.
To measure intermitochondrial CM, we used
probes that can be delivered into the mitochondrial
 .matrix see Section 2 . BCECF-AM is irreversibly
entrapped into the matrix through removal of its
w xacetomethyl group by mitochondrial esterases 50 ;
CMEDA is activated and covalently linked to matrix
Fig. 7. Differential effect of SF-derived protein subfractions and
 .GTP in a RSQ-based, MM-mitochondriarmitochondria MFA. a
 .The assay was carried out with no additions B , or with the
 .  .addition of 50 mgrml G1 ‘ , 50 mgrml G2 v , G1 plus 0.5
 .  .mM GTP = , G2 plus 0.5 mM GTP ’ . Incubations at
 .pHs7.4 and pHs6.5 were as described in Fig. 6. b The MFA
 .was carried out with no protein additions None , or with the
 .  .addition of 50 mgrml G1 G1 or 50 mgrml G2 G2 . For each
of these assays, samples were included without added nucleotide
 .  .None , or with the addition of 200 mM GTP GTP , 100 mM
 .  .GTPg S GTPg S , 200 mM GDP GDP , or 100 GDPb S
 .GDPb S . Four measurements were averaged in each condition
and tested statistically to verify that differences with respect to
samples without added nucleotide are significant. A positive
) . )) .result is indicated with ps0.05 or ps0.01 .
w xproteins 52,53 . The matrix-entrapped fluorescence
 .forms of these probes BCECF and CME were used
as RET donor and acceptor, respectively. We verified
that the absorption spectra of BCECF and the fluores-
cence emission spectra of CME overlap significantly
 .Fig. 8a and that both fluorescence emission spectra
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Fig. 8. Spectral calibration of the fluorescent forms of matrix-en-
 .trappable probes. a Spectral overlap between the normalized
 .emission fluorescence spectra of BCECF ‘ and the absorbance
 .of CME proportional to the excitation spectra; v . Both probes
were entrapped into mitochondria and the organelle later lysed as
 .described in Section 2. b Mixtures containing different propor-
 .tions of mitochondria labeled and lysed as in a were prepared.
Measurements and calculation of RET efficiency described were
carried out for BCECF-labeled plus unlabeled lysed mitochondria
 .F and BCECF-labeled plus CME-labeled lysed mitochondriaA
 .F . The 100% CM value was estimated with the lysate of aDA
50%–50% mixture of BCECF- and CME-labeled mitochondria.
are modified when the probes are brought together in
solution, as expected from RET-coupled fluorophores
w x30 . We also carried out a ‘mock’ experiment using
BCECF- and CME-labeled mitochondria, mixed in
different proportions and hypotonically-lysed Fig.
.8b . RET increases proportionally to the percentage
of probes mixed together. Mixing of these two probes
in the mitochondrial matrix thus leads to a change in
fluorescence consistent with RET.
Using this CM-mitochondriarmitochondria MFA,
 .we studied the effects of the addition of G1 Fig. 9a
 .or G2 Fig. 9b to intact mitochondria. There was a
small degree of time-dependent CM without protein
 .addition, up to about 10% RET efficiency 9% CM .
Addition of G1 to this MFA inhibits this CM compo-
nent to about 2.5% RET efficiency with 200 mg of
Fig. 9. Differential effect of SF-derived protein subfractions in a
RET-based, CM-mitochondriarmitochondria MFA. The MFA
was carried out for mitochondria exposed to various concentra-
 .tions of: a G1, with concentrations in the range 0–200 mgrml.
An additional point with 50 ugrml G1 and 200 mM GTP is
 .  .shown % ; b G2, with concentrations in the range 0–150
mgrml. An additional point with 50 ugrml G2 and 200 mM
 .GTP is shown % . Data were represented as the difference
between RET efficiency at a given time with respect to RET
efficiency at time equal to zero. Symbols used are indicated in
the right side of each plot.
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Table 1
 .Membrane fusion assays MFAs applied to OMM-derived protein subfractions
Additions qG1 qG2 qG1qGTP qG2qGTP
MFA MM CM MM CM MM CM MM CM
a a f f k k n nSUVrLUV qqq qqq qq qq qqq qqq qq qq
b c g h k k o oSUVrM qq qq q y qq qq qq y
d e I j l m p qMrM qq y qq qq qq y qqq qqq




—Fig. 4b increments proportional to G1 concentration added and Fig. 5.
c  .








—Fig. 4b saturable by addition of G2 .
h  .






—Fig. 5; GTP had no additional effect over the addition of G1 alone.
l
—Fig. 7a; GTP had no additional effect over the addition of G1 alone.
m
—Fig. 9a; GTP had no additional effect over the addition of G1 alone.
n




—Fig. 7; positive effect over the addition of G2 alone.
q
—Fig. 9b; GTP had a positive effect over the addition of G2 alone.
 .G1 Fig. 9a . Since G1 was able to induce CM and
 .MM an index of true membrane fusion in the
SUVrLUV and SUVrmitochondria MFA and lead
to increases in the MM-mitochondriarmitochondria
 .MFA Fig. 7 , this result shows that G1 is not
sufficient to induce fusion when acting in a mito-
chondrion–mitochondrion complex. GTP did not af-
fect the CM-mitochondrial MFA with added G1.
Addition of G2 increases CM, up to 40% RET effi-
 .  .ciency 35% CM with 150 mg of G2 Fig. 9b .
Thus, the addition of excess G2 can stimulate mito-
chondrial fusion measured as CM and MM incre-
ments. Since G2 only stimulated the MM-
SUVrmitochondria MFA, the presence of proteins
others that those in G2 is required for intermitochon-
drial CM. As with the other MFAs, the effect of G2
on the CM-mitochondrial MFA was GTP sensitive
 .Fig. 9b . The results of the experiments carried out
with all these MFAs are summarized in Table 1.
4. Discussion
Many studies in cellular fusion are carried out with
one or two assays that detect fusion, commonly
MFAs that use cell membrane ghosts or LUVs to
w xmeasure membrane- or content-mixing 54–56 , or
complex biological assays where fusion is inferred
w xfrom changes in a biological structure 57 , biochemi-
w x w xcal activity 58 , or a biophysical parameter 59 . For
the study of mitochondrial fusion, additional assays
are necessary to dissect putative receptor–activator–
fusogenic protein complexes carrying out regulated
organelle fusion. Ideally, these new MFAs should
reconstitute a subset of the many interactions occur-
ring between these proteins. For example, MFAs
lacking mitochondrial membranes and the putative
proteinaceous receptor that participates in interor-
.ganelle recognition will be sensitive to the effect of
purely fusogenic components. These components will
act directly on the membrane and it will be better
studied without mitochondrial receptors. We also need
MFAs that lack interreceptor interactions, where the
activities of fusogenic or docking proteins inserted in
mitochondrial membranes can be specifically studied
without intermitochondrial interactions. MFAs in-
volving only mitochondrial membranes are essential
to assess, in physiological-like conditions, how the
fusion machinery is activated.
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w xIn a previous paper 28 , we developed two MFAs
to monitor the fusion of SUV with mitochondrial
membranes and detected a membrane fusion compo-
nent occurring at neutral pH. This process could be
related to mitochondrial fusion, a complex membrane
phenomenon that has not been studied at the molecu-
lar level. We have used fluorescence changes to
detect in vitro membrane fusion events. Fluorescence
MFAs assays are very sensitive, detecting a small
number of successful fusion events, an important
property for in vitro assays with dilute organelle
suspensions. In addition, fluorescence-based MFAs
are fast and they can be carried out as a test for
fusogenic fractions collected during protein purifica-
tion. This is important for our task of separating a
complex mixture of OMM proteins into individual
fusion-competent molecules and to obtain informa-
tion about potential regulators. Proteins involved in
fusion can have various roles; they can be part of a
receptor that recognizes specific membranes before
fusion, an activator–inhibitor regulatory protein
molecule, or a protein subunit that belongs to a
fusion-competent molecule.
Initially, using a very mild saltrdetergent treat-
ment that does not compromise mitochondrial inner
w xmembranes 28,32 , we separated a soluble pool of
 .OMM proteins soluble fraction or SF from mito-
chondria. SF increased MM and CM in a RSQ-based
SUVrmitochondria MFA and the SF-stimulated RSQ
 .was specifically sensitive to GTP Fig. 1b . This
experiment suggests that SF proteins may be in-
volved in GTP-dependent membrane fusion occurring
at neutral pH. In addition, this effect of guanine
nucleotides required the presence of mitochondrial
membranes; for the SUVrLUV mitochondria-free
MFA, GTP lacked the effect present with the
SUVrmitochondria MFA. The large low pH- and
SF-dependent increase on MM and CM detected with
the SUVrLUV MFAs suggests that SF enhances
membrane contact between artificial membranes. Ac-
cordingly, experiments involving a very sensitive
 .RET-based MM-MFA Fig. 3 suggested that the
presence in the OMM of some of the proteins solubi-
lized in the SF pool is critical for intermitochondrial
binding to occur. If mitochondria are washed at high
ionic strength, almost no MM is detected. It should
be noted that a purely collisional mechanism for the
MM-mediated increase in RET will lead to an oppo-
site prediction, i.e., that washing out proteins from
the OMM makes available a greater membrane sur-
face for membrane collisions that could produce in-
termembrane lipid transfer.
Membrane-mixing titrations showed unspecific fu-
sion activity for G1 and a saturable, specific-like
 .titration for G2 Fig. 4b . This suggests that, even
though G2 induces increased MM, only a limited
number of G2-mediated contacts between SUV and
mitochondria might occur. Results of the in vitro
CM- and MM-MFAs were also differential for the
 .G1 and G2 subfractions Fig. 5 . G1 increased CM
and MM in all MFAs used, indicative of the presence
of fusogenic proteins, while G2 had different effects
between mitochondrial-containing and mitochondria-
free MFAs. G2 has a more selective effect on the
SUV-mitochondrial MFA, affecting predominantly
MM rather than CM. Comparison between
 .organelle-free MFAs i.e., SUVrLUV and mito-
chondrial MFAs reveals that the presence of mito-
chondria in these MFAs is necessary to produce
fusion and the detected effect of GTP. Addition of
GTP did not modify the SUVrLUV MFA with added
G2, but GTP did increase G2-stimulated MM for the
SUVrmitochondria MFA. The effects of G1 and G2
on MFAs are not additive when compared with SF
 .SFsG1qG2 , which may imply antagonistic G1–
G2 activities or the formation of neutralizing com-
plexes between components of the G1 and G2 sub-
fractions. Addition of GTP had no effect on SF-
stimulated changes for the SUVrLUV MFA and it
only affected the SUVrmitochondria MFA. The
stimulating activity of GTP on the mitochondrial
 .MFAs Figs. 1 and 5 indicates that complexes be-
tween proteins present in SF and the OMM could
form in the presence of GTP, leading to complete
mitochondrial fusion. As fusion occurs only when
CM and MM are concurrent, the predominant MM
effect of G2 suggests that the formation of a complex
precedes an activating fusion step mediated by GTP.
Results from MFAs targeted to intermitochondrial
 .fusion Figs. 6–9 indicate that the differential prop-
erties of G1 and G2 extend to intermitochondrial
fusion. Although both G1 and G2 increased MM
 .between mitochondrial populations Fig. 7 , only G2’s
effect was sensitive to the addition of GTP. In the
 .CM-mitochondriarmitochondria MFA Fig. 9 , G1
showed a concentration-dependent inhibition. The G1
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subfraction thus increases contact between mitochon-
drial membranes, but it can block the ultimate fusion
and mixing between the aqueous matrix spaces. A
fusogenic protein contained in G1 might be binding
to membranes in a non-productive fashion e.g.,
wrong orientation with respect to the plane of the
.membrane , or the added excess of G1 can disrupt the
normal fusion pathways by changing the stoichiom-
etry of productive fusion complexes involving G1
and G2 proteins. Also, this result is inconsistent with
a pure detergent-like effect of the G1 subfraction, as
disruption of mitochondrial structure through unspe-
cific fusion should release matrix-entrapped probes
and lead to increased RET.
The positive effect of the G2 subfraction in both
MM- and CM-mitochondriarmitochondria MFAs
suggests that this subfraction contains proteins com-
petent in membrane fusion. The fact that intermito-
chondrial MM and CM were both enhanced by GTP
indicates that either a component of the G2 subfrac-
tion or its mitochondrial target leads to GTP-stimu-
lated mitochondrial fusion. The effect of guanosine
nucleotides suggests the participation of a GTP-de-
pendent protein. While GDP and GDPb S lacked
effect on stimulating intermitochondrial MM, GTP
and its non-hydrolyzable analog GTPg S stimulated
specifically the G2-dependent effect on MM Fig.
.7b . This effect of GTP and GTPg S is expected from
the activity of a GTP-binding protein that is locked in
its activated state by GTPg S, or displaced kinetically
to such state by excess GTP. GDPb S could be
w xinhibiting by competing with endogenous GTP 60 ,
but this is a variable effect that requires up to mM-
concentrations. Nonetheless, some trend towards in-
hibition was detected in the control and G1-treated
sample.
 .A tabular summary Table 1 of the experiments
carried out with MFAs shows clear differential be-
havior between G1 and G2 added to the various
MFAs systems progressively approaching mitochon-
drial fusion. G1 affects both MM and CM for the
fusion between SUV and LUV or SUV and mito-
 .chondria positive result for fusion . G2 induces lim-
ited stimulation of MM and CM for the SUVrLUV
MFA and only affects MM in the SUVrmitochondria
MFA. Only when mitochondria constitutes both inter-
acting membranes mitochondriarmitochondria
.MFAs , we detected significant G2-stimulated fusion
with increased MM and CM. This will be consistent
with a G2-dependent enhanced contact between mito-
chondrial membranes, probably involving the satura-
tion of a limited number of OMM receptor sites cf.
.Fig. 4b . Thus, G2-stimulated fusion, characterized
by positive CM and MM, requires additional
 .molecules e.g., G1 components in the opposing
membranes.
As discussed before, addition of G1 and GTP gave
similar results to the addition of G1 alone, but GTP
did increase specifically the effects of G2. The prepa-
ration of G2 through selective GTP binding and the
clear effect of GTP in G2-containing mitochondrial
MFAs, both support the hypothesis that one of these
proteins may be a member of the GTPase superfam-
ily, specifically involved in the regulation of mito-
chondrial fusion. The use of data analysis tables such
as Table 1 to codify the results from a set of MFAs
leads to ready comparisons between subfractions ob-
tained from protein separation and to clearly recog-
 .nize the effects of potential activators e.g., GTP . As
the G2 subfraction is composed of only a few protein
bands, isolation of these GTP-binding proteins is now
feasible using the set of MFAs presented here. These
MFAs have the additional advantage of incorporating
both artificial membranes and reconstituted proteins,
which will allow to assess the individual roles of
lipid and protein components of biomembrane fusion.
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